CN103830266A - 部分氧化海藻酸钠羧甲基化衍生物的制备方法和应用 - Google Patents
部分氧化海藻酸钠羧甲基化衍生物的制备方法和应用 Download PDFInfo
- Publication number
- CN103830266A CN103830266A CN201310142860.4A CN201310142860A CN103830266A CN 103830266 A CN103830266 A CN 103830266A CN 201310142860 A CN201310142860 A CN 201310142860A CN 103830266 A CN103830266 A CN 103830266A
- Authority
- CN
- China
- Prior art keywords
- sodium alginate
- product
- partial oxidation
- preparation
- deionized water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000661 sodium alginate Substances 0.000 title claims abstract description 53
- 235000010413 sodium alginate Nutrition 0.000 title claims abstract description 53
- 229940005550 sodium alginate Drugs 0.000 title claims abstract description 53
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000000047 product Substances 0.000 claims abstract description 25
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 21
- 238000006243 chemical reaction Methods 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000008367 deionised water Substances 0.000 claims abstract description 13
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 13
- 239000012286 potassium permanganate Substances 0.000 claims abstract description 11
- 239000012043 crude product Substances 0.000 claims abstract description 10
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 9
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 7
- 238000007254 oxidation reaction Methods 0.000 claims description 25
- 230000003647 oxidation Effects 0.000 claims description 23
- 230000011987 methylation Effects 0.000 claims description 11
- 238000007069 methylation reaction Methods 0.000 claims description 11
- 230000001476 alcoholic effect Effects 0.000 claims description 6
- 229940106681 chloroacetic acid Drugs 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000006166 lysate Substances 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 229940083608 sodium hydroxide Drugs 0.000 claims description 6
- 238000006266 etherification reaction Methods 0.000 claims description 5
- 241001597008 Nomeidae Species 0.000 claims description 4
- 229960002163 hydrogen peroxide Drugs 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- AQLLBJAXUCIJSR-UHFFFAOYSA-N OC(=O)C[Na] Chemical compound OC(=O)C[Na] AQLLBJAXUCIJSR-UHFFFAOYSA-N 0.000 claims description 3
- 230000001009 osteoporotic effect Effects 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 abstract description 3
- 208000010392 Bone Fractures Diseases 0.000 abstract 2
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 238000000967 suction filtration Methods 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 description 13
- 235000010443 alginic acid Nutrition 0.000 description 9
- 229920000615 alginic acid Polymers 0.000 description 9
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 8
- 206010020649 Hyperkeratosis Diseases 0.000 description 8
- 229940072056 alginate Drugs 0.000 description 8
- 230000002980 postoperative effect Effects 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 210000002805 bone matrix Anatomy 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 206010020718 hyperplasia Diseases 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- AEMOLEFTQBMNLQ-AZLKCVHYSA-N (2r,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-AZLKCVHYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-SYJWYVCOSA-N (2s,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-SYJWYVCOSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 150000002009 diols Chemical group 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Images
Landscapes
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310142860.4A CN103830266A (zh) | 2013-04-24 | 2013-04-24 | 部分氧化海藻酸钠羧甲基化衍生物的制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310142860.4A CN103830266A (zh) | 2013-04-24 | 2013-04-24 | 部分氧化海藻酸钠羧甲基化衍生物的制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103830266A true CN103830266A (zh) | 2014-06-04 |
Family
ID=50794370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310142860.4A Pending CN103830266A (zh) | 2013-04-24 | 2013-04-24 | 部分氧化海藻酸钠羧甲基化衍生物的制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103830266A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105461821A (zh) * | 2014-09-05 | 2016-04-06 | 中国石油化工股份有限公司 | 一种醚化改性的海藻胶及其制备方法和含有该海藻胶的水基冻胶压裂液及其应用 |
CN107929310A (zh) * | 2013-04-24 | 2018-04-20 | 王攀峰 | 一种促进骨形成蛋白表达加速骨折愈合的药物的制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6432449B1 (en) * | 1998-05-18 | 2002-08-13 | Amgen Inc. | Biodegradable sustained-release alginate gels |
US6656508B2 (en) * | 1997-04-17 | 2003-12-02 | Amgen Inc. | Sustained-release alginate gels |
CN101260160A (zh) * | 2008-04-23 | 2008-09-10 | 海南大学 | 一种部分氧化海藻酸钠的方法 |
WO2008127290A2 (en) * | 2006-10-12 | 2008-10-23 | The Johns Hopkins University | Alginate and alginate lyase compositions and methods of use |
CN102349929A (zh) * | 2011-09-28 | 2012-02-15 | 郭宏昌 | 一种治疗和预防骨折的药物 |
-
2013
- 2013-04-24 CN CN201310142860.4A patent/CN103830266A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6656508B2 (en) * | 1997-04-17 | 2003-12-02 | Amgen Inc. | Sustained-release alginate gels |
US6432449B1 (en) * | 1998-05-18 | 2002-08-13 | Amgen Inc. | Biodegradable sustained-release alginate gels |
WO2008127290A2 (en) * | 2006-10-12 | 2008-10-23 | The Johns Hopkins University | Alginate and alginate lyase compositions and methods of use |
CN101260160A (zh) * | 2008-04-23 | 2008-09-10 | 海南大学 | 一种部分氧化海藻酸钠的方法 |
CN102349929A (zh) * | 2011-09-28 | 2012-02-15 | 郭宏昌 | 一种治疗和预防骨折的药物 |
Non-Patent Citations (4)
Title |
---|
何淑兰 等: "部分氧化海藻酸钠的制备与性能", 《应用化学》, vol. 22, no. 9, 30 September 2005 (2005-09-30), pages 1007 - 1011 * |
李晓霞 等: "H2O2氧化降解海藻酸钠", 《应用化学》, vol. 26, no. 6, 30 June 2009 (2009-06-30), pages 625 - 628 * |
王孝华: "海藻酸钠的提取及应用", 《重庆工学院学报(自然科学版)》, vol. 21, no. 5, 31 May 2007 (2007-05-31), pages 124 - 128 * |
陈玺 等: "海藻酸钠在临床的应用", 《中国医院药学杂志》, vol. 20, no. 9, 31 December 2000 (2000-12-31), pages 560 - 561 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107929310A (zh) * | 2013-04-24 | 2018-04-20 | 王攀峰 | 一种促进骨形成蛋白表达加速骨折愈合的药物的制备方法 |
CN105461821A (zh) * | 2014-09-05 | 2016-04-06 | 中国石油化工股份有限公司 | 一种醚化改性的海藻胶及其制备方法和含有该海藻胶的水基冻胶压裂液及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5878241B2 (ja) | マイクロ波化学法による褐藻多糖類の抽出方法 | |
CN107141369B (zh) | 一种改性果胶的制备方法 | |
Chiellini et al. | Ulvan: A versatile platform of biomaterials from renewable resources | |
CN103483625B (zh) | 可吸收降解的多用途生物相容性材料 | |
JP7220670B2 (ja) | オゾンを用いた多糖類の分解方法 | |
CN101260160A (zh) | 一种部分氧化海藻酸钠的方法 | |
CN101695581A (zh) | 一种规模制备类人胶原蛋白止血海绵的方法 | |
CN100415304C (zh) | 一种可生物降解止血海绵材料及其制备方法 | |
Bi et al. | Homogeneous modification of chitin and chitosan based on an alkali/urea soluble system and their applications in biomedical engineering | |
TW201429478A (zh) | 用於局部施用之包含玻尿酸和幾丁聚醣之黏膜黏性組成物 | |
CN103113494A (zh) | 一种透明质酸酯复合物的制备方法 | |
JP2016108474A (ja) | オリゴ糖の製造方法およびオリゴ糖 | |
CN107011454B (zh) | 一种低分子量高硫酸化的海参岩藻聚糖硫酸酯制备方法 | |
CN105770983B (zh) | 一种透明质酸生物粘合剂的制备方法 | |
CN104307031B (zh) | 一种皮肤外用修复材料的制备方法及用途 | |
CN107029281A (zh) | 一种可吸收止血材料的制备方法 | |
CN103830266A (zh) | 部分氧化海藻酸钠羧甲基化衍生物的制备方法和应用 | |
CN105153458A (zh) | 一种低水溶性白芨多糖多孔膜的制备方法 | |
CN105622778A (zh) | 一种水溶性壳聚糖的制备方法 | |
CN105168120B (zh) | 一种钙化羧化壳聚糖纳米溶液及其制备方法 | |
CN103665187A (zh) | 一种壳聚糖的制备方法 | |
CN109846985A (zh) | 一种鼻腔疾病辅助治疗清洗剂及其制备方法 | |
CN105131131A (zh) | 一种高羧化度的氧化纤维素的合成方法 | |
JP4566274B2 (ja) | キチンスラリーおよびその製造方法 | |
CN104448038A (zh) | 一种硫酸软骨素钙盐的制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL Free format text: FORMER OWNER: YANG YAQIN Effective date: 20141127 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20141127 Address after: Weihui City, Henan Province, the First Affiliated Hospital of Xinxiang Medical University, 453100 Applicant after: The First Affiliated Hospital of Xinxiang Medical University Address before: Weihui City, Henan Province, the First Affiliated Hospital of Xinxiang Medical University, 453100 Applicant before: Yang Yaqin |
|
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140604 |
|
WD01 | Invention patent application deemed withdrawn after publication |